MedPath

The Acute Effect of Interval-walking

Not Applicable
Completed
Conditions
Type 2 Diabetes Mellitus
Interventions
Behavioral: Continuous walking
Behavioral: Interval Walking
Registration Number
NCT01987258
Lead Sponsor
Rigshospitalet, Denmark
Brief Summary

Four months of interval walking training (IWT) is superior to energy-expenditure matched continuous walking training (CWT) with regards to weight loss and improvements in glycemic control. The reason for this is unclear. One potential explanation for the differential outcome in weight loss is excess post-exercise oxygen consumption (EPOC), which is defined as the elevated oxygen consumption measured during the hours following an exercise bout. A large EPOC means greater energy expenditure which, if energy intake does not change, leads to a greater weight loss. This weight loss may subsequently improve glycemic control

* Aim 1: To assess the effect of an acute bout of IWT vs. an acute bout of CWT on glycemic control in type 2 diabetics and to assess mechanisms responsible for differences (if any). It is hypothesised that IWT will be more advantageous for improving glycemic control.

* Aim 2: To examine the effect of an acute bout of IWT vs. an acute bout of CWT on EPOC. It is hypothesised that IWT will produce an EPOC of larger magnitude than CWT.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Diabetes mellitus, type 2
Exclusion Criteria
  • Smoking
  • Pregnancy
  • insulin dependence
  • Contraindication to physical activity (as judged by medical history and screening)
  • Evidence of thyroid, liver, lung, kidney or heart disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Continuous walkingContinuous walkingA one hour continuous walking exercise bout
Interval WalkingInterval WalkingA one hour interval walking exercise bout
Primary Outcome Measures
NameTimeMethod
Glycemic controlWill be assessed immediately after the intervention using a mixed meal tolerance test (duration: 5 hours) followed by continuous glucose monitoring (duration: 48 hours).

Glycemic control will be assessed after a one hour specific exercise intervention (control/continuous walking/interval walking) in a controlled setting (a mixed meal tolerance test). Moreover, glycemic control will be assessed during the following 2 days in a free-living environment, using continuous glucose monitoring systems.

Secondary Outcome Measures
NameTimeMethod
Excess post-exercise oxygen consumption (EPOC)Will be assessed immediately after the intervention using a ventilated hood (duration: 5 hours).

EPOC will be assessed during the hours following the before-mentioned specific exercise bouts using the indirect calorimetry ventilated hood technique.

Trial Locations

Locations (1)

Centre of Inflammation and Metabolism (CIM), Rigshospitalet, Tagensvej 20, section M7641

🇩🇰

Copenhagen, Denmark

© Copyright 2025. All Rights Reserved by MedPath